TABLES

The following tables illustrate the distribution by technical area of the USAID TB budget for DRC that will be used for the implementation of DRC’s FY 2022 TB Roadmap (Table 1) and the core indicators that will be used to monitor implementation of DRC’s TB Roadmap and the country's progress towards the United Nations General Assembly High-Level Meeting on TB targets (UNGA targets) (Table 2). 

Table 1: USAID Budget for DRC per Technical Area

Technical Area

USAID TB budget 

USAID Percentage of TB budget 

REACH

$6,215,411

44%

CURE

$3,915,230

28%

PREVENT

$1,830,000

13%

SUSTAINABLE SYSTEMS

$2,039,359

15%

TOTAL 

BUDGET:

$14,000,000

100%

Table 2: TB Core Indicators in DRC from 2015-2020 and Targets from 2021-2022

#

Name

2015

2016

2017

2018

2019

2020

2021**

2022**

REACH: Increased DS- and DR-TB case notification

1

TB Detection

48.3%

51.4%

57.3%

62.9%

64.0%

70.26%

 

UNGA Target: 249,000

 

UNGA Target: 233,800

2

Bacteriological Diagnosis Coverage (Pulmonary TB)

82.8%

81.0%

79.5%

77.2%

77.0%

77%

  

3

Childhood TB Notifications

3,062

14,213

16,933

18,453

18,923

22,340

UNGA Target: 32,600

UNGA Target: 31,200

4

Drug-Resistant TB Notifications

503

748

912

787

951

1,059

UNGA Target: 4,900

UNGA Target: 5,200

5

Private Sector TB Notifications

        

6

Contact Investigation Coverage**

    

80.0%

86%

  

CURE: High treatment success rate in DS- and DR-TB

7

TB Treatment Success Rate***

89.5%

88.8%

90.4%

93.0%

92%

   

8

Drug-Resistant TB treatment Success Rate****

86.8%

85.1%

82.0%

84%

    

PREVENT: Prevent TB transmission and development

9

TPT Coverage

--

--

13,045

118,925

64,751

93,740

UNGA Target: 329,520

UNGA Target: 400,350

SUSTAINABLE SYSTEMS: Commitment and sustainability

10

Proportion of Domestic Financing for TB

--

--

4% 

6.5%

3.34%

2%

  
 

*Projected Targets: These represent the United Nations General Assembly High-Level Meeting targets (UNGA targets )

**Contact Investigation Coverage: based on limited available data.

***TB Treatment Success Rate: newest data for 2019 cohort reported.

****Drug-Resistant TB Treatment Success Rate: newest data for 2018 cohort reported.